Nanoco Group expect to go to trial with Samsung on 6 January 2023

Nanoco Group plc (LON:NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, has announced that the Court has notified Nanoco that the case between Nanoco and Samsung has been placed first in the trial schedule that commences on Friday 6 January 2023.

As is the usual practice, the court has scheduled a number of trials for the same date given that, historically, the majority of cases settle before trial. However, the fact that the Nanoco trial has been set first in the schedule, means that it is not dependent on other cases settling in order to proceed.

Brian Tenner, Chief Executive Officer of Nanoco Group plc, said:

“There are now no administrative or legal hurdles to the trial going ahead. Assuming no settlement or other unforeseen event, we now expect to go to trial on 6 January 2023.

“We have maintained our team of witnesses and advisers in a high state of readiness for the last few months and this will continue until the trial is complete. We still expect that the trial will last five working days and therefore expect the jury to return a verdict around 12 January 2023.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical